(Q51963908)

19 April 2018

title

Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient. (English)

1 reference

19 April 2018

0 references

3

1 reference

19 April 2018

author name string

Su KP

series ordinal

1

1 reference

19 April 2018

Shen WW

series ordinal

2

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 August 2001

1 reference

19 April 2018

number of pages

5

1 reference

European Neuropsychopharmacology

inferred from page(s)

published in

1 reference

19 April 2018

volume

11

1 reference

19 April 2018

issue

4

1 reference

19 April 2018

page(s)

295-299

1 reference

19 April 2018

The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Committee on Drugs. American Academy of Pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

The membrane hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Long chain polyunsaturated fatty acids and fetal growth

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Effect of in vivo modulation of membrane docosahexaenoic acid levels on the dopamine-dependent adenylate cyclase activity in the rat retina.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Tissue levels of polyunsaturated fatty acids during early human development

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Are n-3 fatty acids essential nutrients for fetal and infant development?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Sustained Remission of Positive and Negative Symptoms of Schizophrenia Following Treatment With Eicosapentaenoic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Lipids of nervous tissue: composition and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Are omega3 fatty acids beneficial in depression but not mania?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Effects of polyunsaturated fatty acids on psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900098-0

7 January 2021

10.1016/S0924-977X(01)00098-0

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

11532384

1 reference

19 April 2018